In particular, memory MOG181–189-specific CD8+ T cells were significantly increased in MS patients (65.1 ± 11.1%) compared to controls (25.5 ± 11.0%) (Fig. 2E). This evidence concerns the gene CD8A and myeloid sarcoma.